OKL-1111

N/A

Report date: 2025/03/07 13:58:57

Base Information

Drug NameOKL-1111
Drug Alias NameOKL-1111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsPlatelet aggregation inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsHemorrhagic StrokeIntracranial Hemorrhages
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesOkklo Life Sciences BVSanquin Blood Supply Foundation
China Registration ClassN/A

Develop Information

Active CompaniesAlveron Pharma BV
Inactive CompaniesN/A
Active IndicationsHemorrhagic StrokeIntracranial Hemorrhages
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A